Programmable kinetic barcoding for multiplexed RNA detection with Cas13a

Area of Science:

• Molecular Biology
• Biotechnology
• Infectious Disease Diagnostics

Background:

• Accurate and rapid identification of viral infections and variants is crucial for public health.
• Current methods like PCR require DNA amplification, while direct RNA detection assays (CRISPR-Cas13a) lack easy multiplexing capabilities.

Purpose of the Study:

• To develop a multiplexed RNA detection method using CRISPR-Cas13a that avoids DNA sequencing.
• To enable simultaneous detection of multiple viruses and specific SARS-CoV-2 variants from patient samples.

Main Methods:

• Leveraged the variable nuclease activity of Cas13a based on target RNA-crRNA interactions.
• Developed a crRNA modification strategy to program Cas13a's enzymatic rates for kinetic tuning.
• Employed a droplet-based Cas13a assay to analyze kinetic signatures.

Main Results:

• Demonstrated the ability to differentiate between various respiratory viruses and SARS-CoV-2 variants.
• Successfully applied the kinetic barcoding strategy in both contrived and clinical samples.
• Showcased the adaptability of the method for detecting additional RNA targets via crRNA modification.

Conclusions:

• Kinetic barcoding using modified crRNAs offers a novel approach for multiplexed RNA detection with CRISPR-Cas13a.
• This method provides a simple, rapid alternative to DNA sequencing for identifying viral infections and variants.
• The strategy is versatile and can be extended to a broader range of RNA targets.